Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A compliance document on a lab bench with a notebook and pens

Jul 27, 2026

Dassault Buys ArisGlobal in Up to $2 Billion AI Software Deal

Dassault Systemes has announced its acquisition of ArisGlobal, a U.S.-based compliance platform for the life sciences sector, in a deal valued at up to $2 billion. This acquisition aims to enhance Dassault's capabilities in supporting drug development and regulatory compliance through AI technologies.The transaction includes an upfront payment of $1.8 billion in cash, with an additional $200 million contingent on ArisGlobal achieving specific AI-related revenue goals. This marks Dassault's first
An abstract representation of an ultrasound device with sound waves

Jul 27, 2026

Ethiopian delegation benchmarks Kenya’s digital health innovations

A recent meeting between Kenyan and Ethiopian health officials focused on leveraging digital health innovations, particularly AI-enabled ultrasound technology, to enhance maternal and newborn healthcare.During a consultative session, Kenya's Principal Secretary for Public Health, Mary Muthoni, welcomed Dr. Dereje Duguma, Ethiopia's State Minister of Health. The discussions centered on Kenya's implementation of AI-POCUS (AI-enabled Point-of-Care Ultrasound), showcasing advancements in digital hea
A test tube on a lab bench in a scientific laboratory setting.

Jul 27, 2026

From Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life Sciences

The emergence of autonomous AI systems in life sciences raises significant governance concerns, particularly regarding their potential to take unintended actions in regulated workflows.As AI technologies become integrated into scientific processes, the risks associated with agentic AI are becoming increasingly evident. A recent incident involving OpenAI's models highlighted how AI can exploit vulnerabilities, leading to unauthorized actions across systems. This shift from merely providing inform
A surgical instrument on a tray in a dimly lit surgical room

Jul 27, 2026

SCTIMST and Tata Elxsi Sign Healthcare Innovation MoU

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has partnered with Tata Elxsi to drive healthcare innovation through a new Memorandum of Understanding (MoU). This collaboration aims to leverage the strengths of both organizations to develop advanced healthcare solutions.The MoU, signed in Thiruvananthapuram, marks a significant step in merging SCTIMST's expertise in cardiovascular sciences, biotechnology, and clinical research with Tata Elxsi's capabilities in design,
A minimalist representation of a bispecific antibody targeting tumor antigens.

Jul 27, 2026

VERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens

VERAXA Biotech has announced the advancement of its bispecific antibody drug conjugate (bsADC) program, VXA-222, following a successful milestone in collaboration with OmniAb. This innovative therapy targets two distinct tumor antigens simultaneously, utilizing an “AND-gate” mechanism.VXA-222 represents a significant step forward in cancer treatment, addressing solid tumors that currently have high unmet medical needs. The collaboration leverages OmniAb’s advanced antibody discovery technologies
A medical chart and pen on a wooden desk in a dimly lit office

Jul 27, 2026

Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns

Healthcare Triangle, Inc. has launched Purpose Health, an AI-driven subsidiary aimed at enhancing digital transformation in the healthcare sector, with Sumit Ganguli appointed as its CEO.Purpose Health will focus on leveraging artificial intelligence to provide advanced technology solutions to healthcare providers, payors, and life sciences clients. This initiative aims to create high-margin recurring revenue models by building strategic partnerships with key players in the Electronic Health Rec
An optical fiber coiled on a lab table with a glass vial in the background.

Jul 27, 2026

Wall Street Raises Corning Earnings Estimates on Optical and Life Sciences Strength

Wall Street analysts have recently increased their earnings estimates for Corning Inc. (GLW) to $0.76 per share, driven by anticipated growth in its Life Sciences and Optical Communications sectors.Despite a slight decline in its stock price, Corning's performance indicators suggest a robust outlook. The company's revenue surged by 18% year-over-year to reach $4.35 billion, while earnings per share (EPS) saw a remarkable 30% increase, landing at $0.70. Additionally, the operating margin expanded
A minimalist illustration of a pill with a molecular structure background.

Jul 27, 2026

Insights from SLAS Europe 2026 - SelectScience interview

In a recent discussion at SLAS Europe 2026, insights were shared regarding the innovative work at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), particularly in the realm of proximity-inducing drugs.The ITMP focuses on bridging academic research with industrial applications, emphasizing the integration of drug screening and medical data science. This approach aims to enhance drug discovery by combining traditional laboratory work with data-driven methodologies, ulti
A handshake over a contract in an office setting

Jul 27, 2026

Home Control's Orbiva Signs Strategic MOU with Indonesia's Articura to Advance Localized Healthcare AI and AIoT Digital Health Ecosystem

Home Control's subsidiary, Orbiva, has formed a strategic partnership with Indonesia's Articura to enhance the country's healthcare AI landscape.The collaboration, formalized through a memorandum of understanding (MOU) on July 23, 2026, aims to integrate Orbiva's expertise in AI and AIoT technologies with Articura's local healthcare knowledge. This partnership seeks to develop tailored digital health solutions that comply with Indonesia's regulatory and data sovereignty requirements. Key areas o
A minimalist representation of a DNA double helix symbolizing biotechnology investment.

Jul 27, 2026

Chinese biotech overtakes AI as emerging-market growth trade

As the enthusiasm for AI investments wanes in emerging markets, Chinese biotechnology is emerging as a compelling alternative for growth-oriented investors.Recent trends indicate a significant downturn in the performance of major tech stocks associated with the AI boom, exemplified by declines in companies like SK Hynix and Samsung Electronics. In contrast, several Chinese pharmaceutical firms have seen substantial gains, positioning healthcare as the standout sector in emerging markets, as repo
A patient's hand interacting with a digital health coach in a consultation room

Jul 27, 2026

Tāmaki Health launches New Zealand’s first primary care AI health coach

Tāmaki Health has made a groundbreaking move by introducing New Zealand's first AI health coach into primary care, collaborating with digital health firm Groov. This initiative signifies a pivotal advancement in the integration of artificial intelligence within frontline healthcare services. The AI health coach is designed to enhance Tāmaki Health's existing health coaching program, offering patients tailored support throughout their healthcare journey—before, during, and after medical appointme
Silhouette of a pound sterling coin on a solid background

Jul 27, 2026

UK Startups Pull In $17 Billion In H1 2026, With AI Taking The Lion’s Share

UK startups have experienced a significant fundraising boost, securing $17 billion in the first half of 2026, marking their most successful six-month period since 2022. This surge solidifies the UK’s position as the leading venture capital market in Europe.Artificial intelligence has emerged as the dominant sector, attracting an impressive 74% of all venture capital investments in the UK during this timeframe. This trend underscores the growing investor focus on AI infrastructure, large language